Mr. Mainville is currently founder and majority shareholder of LUMA Capital, a private investment holding company, as well as LUMA Life, a private company focusing on the development and commercialization of innovative medical devices. Previously, Mr. Mainville served as Executive Vice President for Cardiome Pharma Corp. as well as President and Chief Executive Officer of Neopharm Labs Inc. and prior to that LAB Research Inc. He has gained considerable experience throughout his career in senior management, operational and corporate finance roles, and served as a director for a number of public and private companies in the biotechnology and pharmaceutical sectors. In particular, Mr. Mainville has led more than 30 mergers and acquisitions, as well as served as Chair of the Audit Committee for a number of Boards, including that of Enobia Pharma, Powertech Corporation, Cyplasin Biomedical, Alethia BioTherapeutics and Bioaxone Therapeutics. He served as Vice-Chairman of BioteCanada, and also teaches corporate governance and mergers and acquisitions courses at McGill University in Montreal, Quebec. Prior to his career in the life science industry, Mr. Mainville was a Senior Vice President and Partner at KPMG.